Real-time enrollment status for this endometrial endometrioid adenocarcinoma clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 5:47 AM UTC
| NCT Number | NCT07436793 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Endometrioid Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 140 participants |
| Active Locations | 4 sites in the US |
| Sponsor | New Mexico Cancer Research Alliance |
| Last Updated on CT.gov | July 2, 2026 (Jul 2, 2026) |
As of September 1, 2026: Clinical trial NCT07436793 is currently recruiting participants. This phase2 study for endometrial endometrioid adenocarcinoma is actively seeking new participants at 4 locations across the United States. The study is sponsored by New Mexico Cancer Research Alliance. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07436793 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07436793 was last updated Jul 2, 2026 (July 2, 2026). HelloStudys verifies this status automatically.